Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Innoviva Inc (NASDAQ:INVA)

11.79
Delayed Data
As of Jul 27
 +0.35 / +3.06%
Today’s Change
6.36
Today|||52-Week Range
16.81
+11.86%
Year-to-Date
Innoviva (INVA) Is Today's Strong On High Volume Stock
Jul 27 / TheStreet.com - Paid Partner Content
Should You Buy Innoviva (INVA) Ahead of Earnings?
Jul 26 / Zacks.com - Paid Partner Content
What's in Store for VeriSign (VRSN) This Earnings Season?
Jul 26 / Zacks.com - Paid Partner Content
What's in Store for Waste Management (WM) in Q2 Earnings?
Jul 26 / Zacks.com - Paid Partner Content
After GILD Earnings, Which Biomed Stock is Best Right Now?
Jul 26 / Zacks.com - Paid Partner Content
Will Stericycle (SRCL) Disappoint this Earnings Season?
Jul 26 / Zacks.com - Paid Partner Content
Changyou.com (CYOU) Q2 Earnings: Is a Surprise in Store?
Jul 26 / Zacks.com - Paid Partner Content
Will Ingersoll-Rand (IR) Surpass Q2 Earnings Estimates?
Jul 26 / Zacks.com - Paid Partner Content
Gilead (GILD) Beats on Q2 Earnings, Cuts 2016 Sales View
Jul 26 / Zacks.com - Paid Partner Content
Will Synaptics (SYNA) Disappoint Again in Q4 Earnings?
Jul 25 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close11.44
Today’s open11.57
Day’s range11.57 - 12.16
Volume838,390
Average volume (3 months)683,450
Market cap$1.3B
Dividend yield8.49%
Data as of 07/27/2016

Growth & Valuation

Earnings growth (last year)+89.33%
Earnings growth (this year)+447.50%
Earnings growth (next 5 years)+3.00%
Revenue growth (last year)+247.57%
P/E ratioNM
Price/Sales17.94
Price/Book--

Competitors

 Today’s
change
Today’s
% change
EBSEmergent BioSolution...+0.34+1.02%
ACORAcorda Therapeutics ...+0.80+3.09%
SRPTSarepta Therapeutics...+0.28+1.15%
SAGESAGE Therapeutics In...+0.80+1.80%
Data as of 07/27/2016

Financials

Last reporting dateJuly 27, 2016
EPS forecast (this quarter)$0.11
Annual revenue (last year)$67.8M
Annual profit (last year)-$18.8M
Net profit margin-27.68%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, Chief Executive Officer &
Director
Michael W. Aguiar
Chief Financial Officer &
Senior Vice President
Eric d'Esparbes
Corporate headquarters
South San Francisco, California

Forecasts

Partner Offers

Search for Jobs